Fundraising Fox

Cofactor Genomics

YC S15 ↗

St. Louis, US · Founded 2015 · Delaware corporation · 13 employees · 8 known investors

cofactorgenomics.com ↗

Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response. The company serves oncology and precision medicine markets by enabling more accurate patient-to-therapy matching.

AI & Machine LearningBiotechHealthtechMedical DevicesDiagnosticsin /cofactorgenomics/@cofactorgenomicycombinator.com ↗
Cofactor Genomics website preview

Founders & leadership· Y Combinator alumni (S15)

DMDave Messina
Dave Messinain𝕏Founder/COO
JGJarret Glasscock
Jarret GlasscockinFounder/CTO
JG
Jarret GlassockExecutive Officer, Director
MA
Matthew A. OckoDirector
JA
Jon ArmstrongDirector
MSMark Siegel
Mark SiegelDirector

Investors · 8

Argonautic VenturesNew York · $5M
Ascension VenturesSaint Louis · $10M – $20M
DCVC (Data Collective)Palo Alto · $5M – $25M
Fifty YearsSan Francisco · $250K – $2M
iSelect FundSt. Louis · $250K – $2M
Menlo VenturesSan Francisco · $1M – $20Mvia Mark Siegel · board
Y CombinatorSan Francisco · $500K
TenOneTen VenturesreportedLos Angeles · $500K – $5M

Reported raises · per SEC filings

Form D private placements
▶$1.2MraisedAug 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HagstromDirector
  • David MessinaExecutive Officer
  • John KuelperExecutive Officer, Director
  • Jarret GlasscockExecutive Officer, Director
  • Mark SiegelDirector
Offering amount
$2M
Amount sold
$1.2M
First sale
Jul 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.9MraisedDec 2021 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jarret GlasscockExecutive Officer, Director
  • David MessinaDirector
  • John KuelperExecutive Officer, Director
  • William HagstromDirector
  • Armen VidianDirector
  • Mark SiegelDirector
  • Jon ArmstrongDirector
Offering amount
$7.1M
Amount sold
$6.9M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.7MraisedJun 2017 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jarret GlassockExecutive Officer, Director
  • Matthew A. OckoDirector
  • Jon ArmstrongDirector
  • Mark SiegelDirector
Offering amount
$15.1M
Amount sold
$10.7M
First sale
Jun 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news